BRIEF-Resverlogix explores potential of Apabetalone in phase 3 Betonmace clinical study
May 24, 2016 at 20:18 PM EDT
* Potential of Apabetalone for treatment of high-risk diabetes and CKD is being explored in co's phase 3 Betonmace clinical study